Urban legends series: Lichen planus

Oral Diseases

Volumn 19, Issue 2, 2013, Pages 128-143

  Baccaglini, L ^a   Thongprasom, K ^b   Carrozzo, M ^c   Bigby, M ^d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Amalgam; Hepatitis; Lichen planus; Mercury; Systematic review; Treatment

Indexed keywords

AMALGAM; PIMECROLIMUS;

ALOE VERA; ARTICLE; CONVENIENCE SAMPLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; HUMAN; LICHEN PLANUS; MEDLINE; META ANALYSIS; PATCH TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; COMPLICATION; HEPATITIS C, CHRONIC; LICHEN PLANUS, ORAL;

HEPATITIS C, CHRONIC; HUMANS; LICHEN PLANUS, ORAL;

EID: 84878164760     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2012.01953.x     Document Type: Article

References (181)

1. Agha-Hosseini F, Borhan-Mojabi K, Monsef-Esfahani HR, Mirzaii-Dizgah I, Etemad-Moghadam S, Karagah A (2010). Efficacy of purslane in the treatment of oral lichen planus. Phytother Res24: 240-244.
2. Alanko K, Kanerva L, Jolanki R, Kannas L, Estlander T (1996). Oral mucosal diseases investigated by patch testing with a dental screening series. Contact Dermatitis34: 263-267.
3. Al-Hashimi I, Schifter M, Lockhart PB et al (2007). Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod103(Suppl): S25.e1-S25.e12.
4. Anonymous (2002). Global prevalence of hepatitis A, B, and C Weekly Epidemiological Record. Vol. 77, 6. Available at: http://www.who.int/docstore/wer/pdf/2002/wer7706.pdf.
5. Anonymous (2011). WHO fact sheet N 164. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/.
6. Arrieta JJ, Rodriguez-Inigo E, Casqueiro M et al (2000). Detection of hepatitis C virus replication by In situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology32: 97-103.
7. Asarch A, Gottlieb AB, Lee J et al (2009). Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. J Am Acad Dermatol61: 104-111.
8. Asselah T, Marcellin P (2011). New direct-acting antivirals' combination for the treatment of chronic hepatitis C. Liver Int31(Suppl 1): 68-77.
9. Axéll T, Henriksen BM (2007). Treatment of gingival lichen with free palatal grafts. J Oral Pathol Med36: 105-109.
10. Axéll T, Zain RB, Siwamogstham P, Tantiniran D, Thampipit J (1990). Prevalence of oral soft tissue lesions in out-patients at two Malaysian and Thai dental schools. Community Dent Oral Epidemiol18: 95-99.
11. Bergdahl J, Ostman PO, Anneroth G, Perris H, Skoglund A (1995). Psychologic aspects of patients with oral lichenoid reactions. Acta Odontol Scand53: 236-241.
12. Bigby M (2009). The relationship between lichen planus and hepatitis C clarified. Arch Dermatol145: 1048-1050.
13. Blackard JT, Kemmer N, Sherman KE (2006). Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences. Hepatology44: 15-22.
14. Bolewska J, Reibel J (1989). T lymphocytes, Langerhans cells and HLA-DR expression on keratinocytes in oral lesions associated with amalgam restorations. J Oral Pathol Med18: 525-528.
15. Bolewska J, Hansen HJ, Holmstrup P, Pindborg JJ, Stangerup M (1990a). Oral mucosal lesions related to silver amalgam restorations. Oral Surg Oral Med Oral Pathol70: 55-58.
16. Bolewska J, Holmstrup P, Moller-Madsen B, Kenrad B, Danscher G (1990b). Amalgam associated mercury accumulations in normal oral mucosa, oral mucosal lesions of lichen planus and contact lesions associated with amalgam. J Oral Pathol Med19: 39-42.
17. Boudreau MD, Beland FA (2006). An evaluation of the biological and toxicological properties of Aloe barbadensis (miller), Aloe vera. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev24: 103-154.
18. Boyd AS, Nanney LB, King LE Jr (1998). Immunoperoxidase evaluation of lichen planus biopsies for hepatitis C virus. Int J Dermatol37: 260-262.
19. Cafaro A, Albanese G, Arduino PG et al (2010). Effect of low-level laser irradiation on unresponsive oral lichen planus: early preliminary results in 13 patients. Photomed Laser Surg28(Suppl 2): S99-S103.
20. Carbone M, Arduino PG, Carrozzo M et al (2009). Topical clobetasol in the treatment of atrophic-erosive oral lichen planus: a randomized controlled trial to compare two preparations with different concentrations. J Oral Pathol Med38: 227-233.
21. Carrozzo M (2008a). How common is oral lichen planus?Evid Based Dent9: 112-113.
22. Carrozzo M (2008b). Oral diseases associated with hepatitis C virus infection. Part 2: lichen planus and other diseases. Oral Dis14: 217-228.
23. Carrozzo M, Thorpe R (2009). Oral lichen planus: a review. Minerva Stomatol58: 519-537.
24. Carrozzo M, Quadri R, Latorre P et al (2002). Molecular evidence that hepatitis C virus replicates in the oral mucosa. J Hepatol37: 364-369.
25. Carrozzo M, Uboldi de Capei M, Dametto E et al (2004). Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol122: 87-94.
26. Carrozzo M, Dametto E, Fasano ME et al (2007). Cytokine gene polymorphisms in hepatitis C virus-related oral lichen planus. Exp Dermatol16: 730-736.
27. Cederbrant K, Hultman P (2000). Characterization of mercuric mercury (Hg2+)-induced lymphoblasts from patients with mercury allergy and from healthy subjects. Clin Exp Immunol121: 23-30.
28. Cederbrant K, Gunnarsson LG, Hultman P, Norda R, Tibbling-Grahn L (1999). In vitro lymphoproliferative assays with HgCl2 cannot identify patients with systemic symptoms attributed to dental amalgam. J Dent Res78: 1450-1458.
29. Chainani-Wu N (2003). Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med9: 161-168.
30. Chainani-Wu N, Silverman S Jr, Reingold A et al (2007). A randomized, placebo-controlled, double-blind clinical trial of curcuminoids in oral lichen planus. Phytomedicine14: 437-446.
31. Chainani-Wu N, Madden E, Lozada-Nur F, Silverman S Jr (2012). High-dose curcuminoids are efficacious in the reduction in symptoms and signs of oral lichen planus. J Am Acad Dermatol66: 752-760.
32. Chang AL, Badger J, Rehmus W, Kimball AB (2008). Alefacept for erosive lichen planus: a case series. J Drugs Dermatol7: 379-383.
33. Chao TJ (2009). Adalimumab in the management of cutaneous and oral lichen planus. Cutis84: 325-328.
34. Cheng A, Mann C (2006). Oral erosive lichen planus treated with efalizumab. Arch Dermatol142: 680-682.
35. Choonhakarn C, Busaracome P, Sripanidkulchai B, Sarakarn P (2008). The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial. Br J Dermatol158: 573-577.
36. Chuang TY, Stitle L, Brashear R, Lewis C (1999). Hepatitis C virus and lichen planus: a case-control study of 340 patients. J Am Acad Dermatol41: 787-789.
37. Cilurzo F, Gennari CG, Selmin F et al (2010). A new mucoadhesive dosage form for the management of oral lichen planus: formulation study and clinical study. Eur J Pharm Biopharm76: 437-442.
38. Cohen Tervaert JW, Van Paassen P, Damoiseaux J (2007). Type II cryoglobulinemia is not associated with hepatitis C infection: the Dutch experience. Ann N Y Acad Sci1107: 251-258.
39. Cornberg M, Razavi HA, Alberti A et al (2011). A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int31(Suppl 2): 30-60.
40. Curry N, Stanworth S, Hopewell S, Dorée C, Brohi K, Hyde C (2011). Trauma-induced coagulopathy--a review of the systematic reviews: is there sufficient evidence to guide clinical transfusion practice?Transfus Med Rev25: 217-231.
41. Dal Maso L, Franceschi S (2006). Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev15: 2078-2085.
42. Dalmau J, Puig L, Roé E, Peramiquel L, Campos M, Alomar A (2007). Successful treatment of oral erosive lichen planus with mycophenolate mofetil. J Eur Acad Dermatol Venereol21: 259-260.
43. Ding G, Wang W, Liu Y, Zhang C, Wang S (2011). Mesenchymal stem cell transplantation: a potential therapy for oral lichen planus. Med Hypotheses76: 322-324.
44. Ditrichova D, Kapralova S, Tichy M et al (2007). Oral lichenoid lesions and allergy to dental materials. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub151: 333-339.
45. Dunsche A, Kastel I, Terheyden H, Springer IN, Christophers E, Brasch J (2003). Oral lichenoid reactions associated with amalgam: improvement after amalgam removal. Br J Dermatol148: 70-76.
46. Erkek E, Bozdogan O, Olut AI (2001). Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol26: 540-544.
47. Eversole LR, Ringer M (1984). The role of dental restorative metals in the pathogenesis of oral lichen planus. Oral Surg Oral Med Oral Pathol57: 383-387.
48. Eyeson J, House I, Yang YH, Warnakulasuriya KA (2010). Relationship between mercury levels in blood and urine and complaints of chronic mercury toxicity from amalgam restorations. Br Dent J208: E7; discussion 162-163.
49. Femiano F, Scully C (2005). Functions of the cytokines in relation oral lichen planus-hepatitis C. Med Oral Patol Oral Cir Bucal10(Suppl 1): E40-E44.
50. Finne K, Goransson K, Winckler L (1982). Oral lichen planus and contact allergy to mercury. Int J Oral Surg11: 236-239.
51. Gandolfo S, Carbone M, Carrozzo M, Gallo V (1994). Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 casesJ Oral Pathol Med23: 119-122.
52. Gandolfo S, Carrozzo M, Pagano M (2004). Oral lichenoid lesions: what are they?Oral Oncol40: 1057-1058.
53. Garhammer P, Schmalz G, Hiller KA, Reitinger T, Stolz W (2001). Patients with local adverse effects from dental alloys: frequency, complaints, symptoms, allergy. Clin Oral Investig5: 240-249.
54. Gencoglan G, Inanir İ, Sahin O, Gunduz K (2011). Imiquimod 5% cream for isolated lichen planus of the lip. J Dermatolog Treat22: 55-59.
55. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R (2003). Prevalence of hepatitis C virus infection in porphyria cutanea tarda: systematic review and meta-analysis. J Hepatol39: 620-627.
56. Gorouhi F, Solhpour A, Beitollahi JM et al (2007). Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus. J Am Acad Dermatol57: 806-813.
57. Gottwald B, Traenckner I, Kupfer J et al (2001). "Amalgam disease"- poisoning, allergy, or psychic disorder?Int J Hyg Environ Health204: 223-229.
58. Grossman S, Garcia BG, Soares I, Monteiro L, Mesquita R (2008). Amalgam-associated oral lichenoid reaction: case report and management. Gen Dent56: e9-e11.
59. Harden D, Skelton H, Smith KJ (2003). Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus. J Am Acad Dermatol49: 847-852.
60. Henriksson E, Mattsson U, Hakansson J (1995). Healing of lichenoid reactions following removal of amalgam. A clinical follow-up. J Clin Periodontol22: 287-294.
61. Hietanen J, Pihlman K, Forstrom L, Linder E, Reunala T (1987). No evidence of hypersensitivity to dental restorative metals in oral lichen planus. Scand J Dent Res95: 320-327.
62. Holló P, Szakonyi J, Kiss D, Jokai H, Horváth A, Kárpáti S (2011). Successful treatment of lichen planus with Adalimumab. Acta Derm Venereol November 21. doi: 10.2340/00015555-1249 [Epub ahead of print].
63. Ibbotson SH, Speight EL, Macleod RI, Smart ER, Lawrence CM (1996). The relevance and effect of amalgam replacement in subjects with oral lichenoid reactions. Br J Dermatol134: 420-423.
64. Issa Y, Brunton PA, Glenny AM, Duxbury AJ (2004). Healing of oral lichenoid lesions after replacing amalgam restorations: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod98: 553-565.
65. Issa Y, Duxbury AJ, Macfarlane TV, Brunton PA (2005). Oral lichenoid lesions related to dental restorative materials. Br Dent J198: 361-366; discussion 549; quiz 372.
66. Jajarm HH, Falaki F, Mahdavi O (2011). A comparative pilot study of low intensity laser versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus. Photomed Laser Surg29: 421-425.
67. James J, Ferguson MM, Forsyth A, Tulloch N, Lamey PJ (1987). Oral lichenoid reactions related to mercury sensitivity. Br J Oral Maxillofac Surg25: 474-480.
68. Jones TW (1885). An instrument for the transfusion of defibrinated blood. Br Med J1: 1198.
69. Jontell M, Stahlblad PA, Rosdahl I, Lindblom B (1987). HLA-DR3 antigens in erosive oral lichen planus, cutaneous lichen planus, and lichenoid reactions. Acta Odontol Scand45: 309-312.
70. van Joost T, Laeijendecker R (1993). Amalgam. VI. Allergy to mercury in dental materials; oral and systemic reactions. Ned Tijdschr Tandheelkd100: 303-307.
71. Kallus T, Mjor IA (1991). Incidence of adverse effects of dental materials. Scand J Dent Res99: 236-240.
72. Koch P, Bahmer FA (1995). Oral lichenoid lesions, mercury hypersensitivity and combined hypersensitivity to mercury and other metals: histologically-proven reproduction of the reaction by patch testing with metal salts. Contact Dermatitis33: 323-328.
73. Koch P, Bahmer FA (1999). Oral lesions and symptoms related to metals used in dental restorations: a clinical, allergological, and histologic study. J Am Acad Dermatol41: 422-430.
74. Kurokawa M, Hidaka T, Sasaki H, Nishikata I, Morishita K, Setoyama M (2003). Analysis of hepatitis C virus (HCV) RNA in the lesions of lichen planus in patients with chronic hepatitis C: detection of anti-genomic- as well as genomic strand HCV RNAs in lichen planus lesions. J Dermatol Sci32: 65-70.
75. Laeijendecker R, Dekker SK, Burger PM, Mulder PG, Van Joost T, Neumann MH (2004). Oral lichen planus and allergy to dental amalgam restorations. Arch Dermatol140: 1434-1438.
76. Laine J, Kalimo K, Forssell H, Happonen RP (1992). Resolution of oral lichenoid lesions after replacement of amalgam restorations in patients allergic to mercury compounds. Br J Dermatol126: 10-15.
77. Laine J, Happonen RP, Vainio O, Kalimo K (1997a). In vitro lymphocyte proliferation test in the diagnosis of oral mucosal hypersensitivity reactions to dental amalgam. J Oral Pathol Med26: 362-366.
78. Laine J, Kalimo K, Happonen RP (1997b). Contact allergy to dental restorative materials in patients with oral lichenoid lesions. Contact Dermatitis36: 141-146.
79. Laine J, Konttinen YT, Beliaev N, Happonen RP (1999). Immunocompetent cells in amalgam-associated oral lichenoid contact lesions. J Oral Pathol Med28: 117-121.
80. Langworth S, Bjorkman L, Elinder CG, Jarup L, Savlin P (2002). Multidisciplinary examination of patients with illness attributed to dental fillings. J Oral Rehabil29: 705-713.
81. Lapane KL, Jakiche AF, Sugano D, Weng CS, Carey WD (1998). Hepatitis C infection risk analysis: who should be screened? Comparison of multiple screening strategies based on the National Hepatitis Surveillance ProgramAm J Gastroenterol93: 591-596.
82. Larsson A, Warfvinge G (1995). The histopathology of oral mucosal lesions associated with amalgam or porcelain-fused-to-metal restorations. Oral Dis1: 152-158.
83. Larsson A, Warfvinge G (1998). Immunohistochemistry of 'tertiary lymphoid follicles' in oral amalgam-associated lichenoid lesions. Oral Dis4: 187-193.
84. Lazaro P, Olalquiaga J, Bartolome J et al (2002). Detection of hepatitis C virus RNA and core protein in keratinocytes from patients with cutaneous lichen planus and chronic hepatitis C. J Invest Dermatol119: 798-803.
85. Lind PO (1988). Oral lichenoid reactions related to composite restorations. Preliminary report. Acta Odontol Scand46: 63-65.
86. Lind PO, Hurlen B, Lyberg T, Aas E (1986). Amalgam-related oral lichenoid reaction. Scand J Dent Res94: 448-451.
87. Little MC, Watson RE, Pemberton MN, Griffiths CE, Thornhill MH (2001). Activation of oral keratinocytes by mercuric chloride: relevance to dental amalgam-induced oral lichenoid reactions. Br J Dermatol144: 1024-1032.
88. Little MC, Griffiths CE, Watson RE, Pemberton MN, Thornhill MH (2003). Oral mucosal keratinocytes express RANTES and ICAM-1, but not interleukin-8, in oral lichen planus and oral lichenoid reactions induced by amalgam fillings. Clin Exp Dermatol28: 64-69.
89. Lodi G, Pellicano R, Carrozzo M (2010). Hepatitis C virus infection and lichen planus: a systematic review with meta-analysis. Oral Dis16: 601-612.
90. Lopez-Jornet P, Camacho-Alonso F (2008). Do metal restorations in mouth alter clinical and histological appearance of oral lichen planus?N Y State Dent J74: 40-43.
91. Lopez-Jornet P, Camacho-Alonso F, Gomez-Garcia F, Bermejo Fenoll A (2004). The clinicopathological characteristics of oral lichen planus and its relationship with dental materials. Contact Dermatitis51: 210-211.
92. Lozada-Nur FI, Sroussi HY (2006). Tacrolimus powder in Orabase 0.1% for the treatment of oral lichen planus and oral lichenoid lesions: an open clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod102: 744-749.
93. Lundstrom IM (1984). Allergy and corrosion of dental materials in patients with oral lichen planus. Int J Oral Surg13: 16-24.
94. Lygre GB, Gjerdet NR, Gronningsaeter AG, Bjorkman L (2003). Reporting on adverse reactions to dental materials - intraoral observations at a clinical follow-up. Community Dent Oral Epidemiol31: 200-206.
95. Machado MA, Contar CM, Brustolim JA et al (2010). Management of two cases of desquamative gingivitis with clobetasol and Calendula officinalis gel. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub154: 335-338.
96. Malhotra AK, Khaitan BK, Sethuraman G, Sharma VK (2008). Betamethasone oral mini-pulse therapy compared with topical triamcinolone acetonide (0.1%) paste in oral lichen planus: a randomized comparative study. J Am Acad Dermatol58: 596-602.
97. Mangia A, Andriulli A, Zenarola P et al (1999). Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients. J Med Virol59: 277-280.
98. Mansourian A, Momen-Heravi F, Saheb-Jamee M, Esfehani M, Khalilzadeh O, Momen-Beitollahi J (2011). Comparison of aloe vera mouthwash with triamcinolone acetonide 0.1% on oral lichen planus: a randomized double-blinded clinical trial. Am J Med Sci342: 447-451.
99. Martin MD, Drangsholt M (2005). Oral lichenoid lesions associated with dental amalgam restorations: a 60-year-old woman with a 7-year history of painful, erosive mucosal lesions. J Evid Based Dent Pract5: 131-138.
100. Martin MD, Broughton S, Drangsholt M (2003). Oral lichen planus and dental materials: a case-control study. Contact Dermatitis48: 331-336.
101. Mattsson U, Heyden G, Chodorowski A, Gustavsson T, Jontell M, Bergquist F (1994). Computer analysis in oral lichenoid reactions. Acta Odontol Scand52: 86-92.
102. McCaughey C, Machan M, Bennett R, Zone JJ, Hull CM (2011). Pimecrolimus 1% cream for oral erosive lichen planus: a 6-week randomized, double-blind, vehicle-controlled study with a 6-week open-label extension to assess efficacy and safety. J Eur Acad Dermatol Venereol25: 1061-1067.
103. McGivern B, Pemberton M, Theaker ED, Buchanan JA, Thornhill MH (2000). Delayed and immediate hypersensitivity reactions associated with the use of amalgam. Br Dent J188: 73-76.
104. Merkinaite S, Lazarus JV, Gore C (2008). Addressing HCV infection in Europe: reported, estimated and undiagnosed cases. Cent Eur J Public Health16: 106-110.
105. Mobacken H, Hersle K, Sloberg K, Thilander H (1984). Oral lichen planus: hypersensitivity to dental restoration material. Contact Dermatitis10: 11-15.
106. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol62: 1006-1012.
107. Mokni M, Rybojad M, Puppin D Jr et al (1991). Lichen planus and hepatitis C virus. J Am Acad Dermatol24: 792.
108. Moss AC, Treister NS, Marsee DK, Cheifetz AS (2007). Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab. Gastroenterology132: 488, 829.
109. Mousavi F, Sherafati S, Mojaver YN (2009). Ignatia in the treatment of oral lichen planus. Homeopathy98: 40-44.
110. Muller AW, Van Loon LA, Davidson CL (1990). Electrical potentials of restorations in subjects without oral complaints. J Oral Rehabil17: 419-424.
111. Musumeci ML, Lacarrubba F, Micali G (2010). Onset of lichen planus during treatment with etanercept. Am J Clin Dermatol11(Suppl 1): 55-56.
112. Nagao Y, Sata M (2011). Effect of oral care gel on the quality of life for oral lichen planus in patients with chronic HCV infection. Virol J8: 348.
113. Nagao Y, Sata M, Noguchi S, Kinoshita M, Kameyama T, Ueno T (2000). Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. J Oral Pathol Med29: 259-266.
114. Nakayama H, Oshiro A, Sato S, Nakano N (1972). 2 cases of lichen planus apparently caused by allergy to dental metals. Jibiinkoka44: 239-247.
115. Negro F, Lau JY (1999). In situ detection of HCV: an overview. Methods Mol Med19: 237-248.
116. Nogi N (1989). [Electric current around dental metals as a factor producing allergenic metal ions in the oral cavity]. Nihon Hifuka Gakkai Zasshi99: 1243-1254.
117. Nolan A, Badminton J, Maguire J, Seymour RA (2009). The efficacy of topical hyaluronic acid in the management of oral lichen planus. J Oral Pathol Med38: 299-303.
118. Nordlind K, Liden S (1992). Patch test reactions to metal salts in patients with oral mucosal lesions associated with amalgam restorations. Contact Dermatitis27: 157-160.
119. Ostman PO, Anneroth G, Skoglund A (1994). Oral lichen planus lesions in contact with amalgam fillings: a clinical, histologic, and immunohistochemical study. Scand J Dent Res102: 172-179.
120. Ostman PO, Anneroth G, Johansson I, Stegmayr B, Skoglund A (1996a). Life-style survey of patients with oral lichenoid reactions. Acta Odontol Scand54: 96-101.
121. Ostman PO, Anneroth G, Skoglund A (1996b). Amalgam-associated oral lichenoid reactions. Clinical and histologic changes after removal of amalgam fillings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod81: 459-465.
122. Pang BK, Freeman S (1995). Oral lichenoid lesions caused by allergy to mercury in amalgam fillings. Contact Dermatitis33: 423-427.
123. Parmentier L, Bron BA, Prins C, Samson J, Masouye′ I, Borradori L (2008). Mucocutaneous lichen planus with esophageal involvement: successful treatment with an anti-CD20 monoclonal antibody. Arch Dermatol144: 1427-1430.
124. Passeron T, Lacour JP, Fontas E, Ortonne JP (2007). Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. Arch Dermatol143: 472-476.
125. Pecegueiro M, Sachse MF, Amaro J, Farinha P, Fonseca I (1999). Oral lichen planus versus oral lichenoid eruption as a manifestation of contact allergy. Contact Dermatitis40: 333-334.
126. Peker I, Alkurt MT, Usalan G (2008). Clinical evaluation of medications on oral and dental health. Int Dent J58: 218-222.
127. Petti S, Rabiei M, De Luca M, Scully C (2011). The magnitude of the association between hepatitis C virus infection and oral lichen planus: meta-analysis and case control study. Odontology99: 168-178.
128. Pezelj-Ribaric S, Prpic J, Miletic I, Brumini G, Soskic MS, Anic I (2008). Association between oral lichenoid reactions and amalgam restorations. J Eur Acad Dermatol Venereol22: 1163-1167.
129. Pilli M, Penna A, Zerbini A et al (2002). Oral lichen planus pathogenesis: a role for the HCV-specific cellular immune response. Hepatology36: 1446-1452.
130. Raap U, Stiesch M, Reh H, Kapp A, Werfel T (2009). Investigation of contact allergy to dental metals in 206 patients. Contact Dermatitis60: 339-343.
131. Rebora A, Parodi A, Murialdo G (2002). Basiliximab is effective for erosive lichen planus. Arch Dermatol138: 1100-1101.
132. Reich K, Sinclair R, Roberts G, Griffiths CE, Tabberer M, Barker J (2008). Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis. Curr Med Res Opin24: 1237-1254.
133. Rein DB, Smith BD, Wittenborn JS et al (2012). The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med156: 263-270.
134. Rein DB, Wittenborn JS, Weinbaum CM, Sabin M, Smith BD, Lesesne SB (2011). Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States. Dig Liver Dis43: 66-72.
135. Revie D, Salahuddin SZ (2011). Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J8: 346.
136. Robinson JK, Dellavalle RP, Bigby M, Callen JP (2008). Systematic reviews: grading recommendations and evidence quality. Arch Dermatol144: 97-99.
137. Roy K, Dickson EM, Konrad SS, Bagg J (2000). Hepatitis C virus and oral lichen planus/lichenoid reactions: lack of evidence for an association. Clin Lab46: 251-254.
138. Salazar-Sánchez N, López-Jornet P, Camacho-Alonso F, Sánchez-Siles M (2010). Efficacy of topical Aloe vera in patients with oral lichen planus: a randomized double-blind study. J Oral Pathol Med39: 735-740.
139. Sankar V, Hearnden V, Hull K et al (2011). Local drug delivery for oral mucosal diseases: challenges and opportunities. Oral Dis17(Suppl 1): 73-84.
140. Sansonno D, Cornacchiulo V, Iacobelli AR, Di Stefano R, Lospalluti M, Dammacco F (1995). Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology21: 305-312.
141. Santoro A, Majorana A, Roversi L et al (2005). Recruitment of dendritic cells in oral lichen planus. J Pathol205: 426-434.
142. Schiodt M (1984). Oral discoid lupus erythematosus. III. A histopathologic study of sixty-six patients. Oral Surg Oral Med Oral Pathol57: 281-293.
143. Schuurs AH, van Amerongen JP (1996). General health damage by restorations of composite. Ned Tijdschr Tandheelkd103: 444-447.
144. Scott A, Egner W, Gawkrodger DJ et al (2004). The national survey of adverse reactions to dental materials in the UK: a preliminary study by the UK Adverse Reactions Reporting Project. Br Dent J196: 471-477; discussion 465.
145. Shaker OG, Hantar N, El-Tahlawi S et al (2009). Detection of myxovirus resistance protein A in lichen planus lesions and its relationship to hepatitis C virus. Br J Dermatol160: 980-983.
146. Shapira MY, Abdul-Hai A, Resnick IB et al (2009). Alefacept treatment for refractory chronic extensive GVHD. Bone Marrow Transplant43: 339-343.
147. Shelton RM (1991). Aloe vera; its chemical and therapeutic properties. Int J Dermatol30: 679-683.
148. Shengyuan L, Songpo Y, Wen W et al (2009). Hepatitis C virus and lichen planus: a reciprocal association determined by a meta-analysis. Arch Dermatol145: 1040-1047.
149. Skoglund A (1994). Value of epicutaneous patch testing in patients with oral, mucosal lesions of lichenoid character. Scand J Dent Res102: 216-222.
150. Skoglund A, Egelrud T (1991). Hypersensitivity reactions to dental materials in patients with lichenoid oral mucosal lesions and in patients with burning mouth syndrome. Scand J Dent Res99: 320-328.
151. Smart ER, Macleod RI, Lawrence CM (1995). Resolution of lichen planus following removal of amalgam restorations in patients with proven allergy to mercury salts: a pilot study. Br Dent J178: 108-112.
152. Soria A, Agbo-Godeau S, Taïeb A, Francès C (2009). Treatment of refractory oral erosive lichen planus with topical rapamycin: 7 cases. Dermatology218: 22-25.
153. Stejskal VD, Forsbeck M, Cederbrant KE, Asteman O (1996). Mercury-specific lymphocytes: an indication of mercury allergy in man. J Clin Immunol16: 31-40.
154. Sugerman PB, Satterwhite K, Bigby M (2000). Autocytotoxic T-cell clones in lichen planus. Br J Dermatol142: 449-456.
155. Sugerman PB, Savage NW, Walsh LJ et al (2002). The pathogenesis of oral lichen planus. Crit Rev Oral Biol Med13: 350-365.
156. Swartzendruber DE (1993). The possible relationship between mercury from dental amalgam and diseases. I: Effects within the oral cavity. Med Hypotheses41: 31-34.
157. Swift JC, Rees TD, Plemons JM, Hallmon WW, Wright JC (2005). The effectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus. J Periodontol76: 627-635.
158. Thongprasom K, Carrozzo M, Furness S, Lodi G (2011). Interventions for treating oral lichen planus. Cochrane Database Syst Rev7: CD001168.
159. Thornhill MH (2006). Oral lichenoid lesions and amalgam fillings. Evid Based Dent7: 74-75.
160. Thornhill MH, Pemberton MN, Simmons RK, Theaker ED (2003). Amalgam-contact hypersensitivity lesions and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod95: 291-299.
161. Torti DC, Jorizzo JL, McCarty MA (2007). Oral lichen planus: a case series with emphasis on therapy. Arch Dermatol143: 511-515.
162. Turan H, Baskan EB, Tunali S, Yazici S, Saricaoglu H (2009). Methotrexate for the treatment of generalized lichen planus. J Am Acad Dermatol60: 164-166.
163. Veien NK (1990). Stomatitis and systemic dermatitis from mercury in amalgam dental restorations. Dermatol Clin8: 157-160.
164. Vogler BK, Ernst E (1999). Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract49: 823-828.
165. Volz T, Caroli U, Lüdtke H et al (2008). Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study. Br J Dermatol159: 936-941.
166. van der Waal I (2009). Oral lichen planus and oral lichenoid lesions; a critical appraisal with emphasis on the diagnostic aspects. Med Oral Patol Oral Cir Bucal14: E310-E314.
167. Warfvinge G, Hellman M, Maroti M, Ahlstrom U, Larsson A (1994). Hg-provocation of oral mucosa in patients with oral lichenoid lesions. Scand J Dent Res102: 34-40.
168. Weng JY, Du X, Geng SX et al (2010). Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant45: 1732-1740.
169. Wong L, Freeman S (2003). Oral lichenoid lesions (OLL) and mercury in amalgam fillings. Contact Dermatitis48: 74-79.
170. Worthington HV, Clarkson JE, Bryan G et al (2011). Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev13: CD000978.
171. Wright J (2007). Diagnosis and management of oral lichenoid reactions. J Calif Dent Assoc35: 412-416.
172. Wu Y, Zhou G, Zeng H, Xiong CR, Lin M, Zhou HM (2010). A randomized double-blind, positive-control trial of topical thalidomide in erosive oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod110: 188-195.
173. Xiong C, Li Q, Lin M et al (2009). The efficacy of topical intralesional BCG-PSN injection in the treatment of erosive oral lichen planus: a randomized controlled trial. J Oral Pathol Med38: 551-558.
174. Xu YZ, Geng Y, Liu YX, Fuan YQ, Li J (2002). Clinical study on three-step treatment of oral lichen planus by integrated traditional and western medicine. J Modern Stomatol16: 344-346.
175. Yagi A, Kabash A, Okamura N et al (2002). Antioxidant, free radical scavenging and anti-inflammatory effects of aloesin derivatives in aloe vera. Planta Med68: 957-960.
176. Yarom N (2007). Etanercept for the management of oral lichen planus. Am J Clin Dermatol8: 121.
177. Yuan WJ, Zhao HJ, Kong L, Wu ZY (1993). Lichen like lesion of the oral mucosa caused by amalgam filling: report of one case. Shanghai Kou Qiang Yi Xue2: 180-181.
178. Zhang J, Yu KF (1998). What's the relative risk? a method of correcting the odds ratio in cohort studies of common outcomes. JAMA280: 1690-1691.
179. Zheng LW, Hua H, Cheung LK (2011). Traditional Chinese medicine and oral diseases: today and tomorrow. Oral Dis17: 7-12.
180. Zhou H, Guo M, Bian C et al (2010). Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report. Biol Blood Marrow Transplant16: 403-412.
181. Zhu YX (1989). Clinical and histologic analysis of mucous membrane lesions associated with dental restoration. Zhonghua Kou Qiang Yi Xue Za Zhi24: 49-51, 63.